Document is current

Any future updates will be listed below

Superior efficacy of empagliflozin and finerenone combination therapy versus monotherapy in patients with CKD and T2DM

Crossref DOI link: https://doi.org/10.1038/s41581-025-00986-7

Published Online: 2025-06-27

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark